日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

在法国的一项早期用药计划中,达卡他韦联合索非布韦(可联合或不联合利巴韦林)用于治疗丙型肝炎病毒基因3型感染。

Hézode, Christophe; Lebray, Pascal; De Ledinghen, Victor; Zoulim, Fabien; Di Martino, Vincent; Boyer, Nathalie; Larrey, Dominique; Botta-Fridlund, Danielle; Silvain, Christine; Fontaine, Hélène; D'Alteroche, Louis; Leroy, Vincent; Bourliere, Marc; Hubert-Fouchard, Isabelle; Guyader, Dominique; Rosa, Isabelle; Nguyen-Khac, Eric; Fedchuk, Larysa; Akremi, Raoudha; Bennai, Yacia; Filipovics, Anne; Zhao, Yue; Bronowicki, Jean-Pierre

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

在法国早期准入队列中,达卡他韦和索非布韦联合或不联合利巴韦林治疗HIV/HCV合并感染合并晚期肝病患者的真实世界疗效

Lacombe, Karine; Fontaine, Hélène; Dhiver, Catherine; Metivier, Sophie; Rosenthal, Eric; Antonini, Teresa; Valantin, Marc Antoine; Miailhes, Patrick; Harent, Stanislas; Batisse, Dominique; Pageaux, Georges-Philippe; Chas, Julie; Aumaitre, Hugues; Dominguez, Stephanie; Allegre, Thierry; Lafeuillade, Alain; Billaud, Eric; De Truchis, Pierre; Perre, Philippe; Leroy, Vincent; De Ledinghen, Victor; Sogni, Philippe; Dabis, François; Zhao, Yue; Filipovics, Anne; Fedchuk, Larysa; Akremi, Raoudha; Bennai, Yacia; Salmon Ceron, Dominique